Kartos Therapeutics, Inc. logo

Kartos Therapeutics, Inc. Employee Directory

Biotechnology ResearchCalifornia, United States51-200 Employees

Kartos Therapeutics, Inc. is a privately held, clinical-stage biotechnology company focused on developing targeted cancer therapies through an MDM2 inhibitor program. Its lead candidate, navtemadlin (KRT-232), is designed to address hematologic and oncologic diseases by modulating the MDM2–p53 pathway. Founded in 2018 and headquartered in Redwood City, California, with operations in Bellevue, Washington, Kartos has assembled a team with extensive hematology and oncology expertise.

In its market, Kartos collaborates with researchers, clinicians, and industry partners pursuing new cancer therapies and diagnostic tools. A recent development is a collaboration with Tempus to develop a companion diagnostic test to support navtemadlin's Phase II study.

Find Kartos Therapeutics, Inc. employees' phone numbers or email addresses

Kartos Therapeutics, Inc. Global Highlights

Location
Employees

North America
71

Minus sign iconPlus sign icon
  • United States Of America
    67
  • Canada
    3
  • Mexico
    1

Europe
6

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    3
  • Poland
    2
  • Denmark
    1

Asia
1

Minus sign iconPlus sign icon
  • United Arab Emirates
    1

Kartos Therapeutics, Inc.'s Leadership

  • President at Kartos Therapeutics, Inc.
    W. R.
    President
  • Senior Vice President - Strategy & Business Development at Kartos Therapeutics, Inc.
    R. M.
    Senior Vice President - Strategy & Business Development
  • Senior Vice President Clinical Development Operations at Kartos Therapeutics, Inc.
    J. M.
    Senior Vice President Clinical Development Operations
  • Vice President at Kartos Therapeutics, Inc.
    H. Q.
    Vice President
  • Director, Clinical Operations at Kartos Therapeutics, Inc.
    T. S.
    Director, Clinical Operations
  • Executive Director, Clinical Science at Kartos Therapeutics, Inc.
    E. P.
    Executive Director, Clinical Science
  • Director, Finance at Kartos Therapeutics, Inc.
    T. B.
    Director, Finance
  • Senior Clinical Trial Manager at Kartos Therapeutics, Inc.
    R. P.
    Senior Clinical Trial Manager

Kartos Therapeutics, Inc. Employee Metrics

100%
50%
0%
2026
2025
  • Business
  • Sales
  • Biotechnology
  • Branding
  • Human Resources
  • Other
  • Legal
  • Healthcare Services
  • Entrepreneurship

Contact profiles from Kartos Therapeutics, Inc.

Name
Title
Contact
Location
Last Update
  • President at Kartos Therapeutics, Inc.
    W. R.
    President
    Oct 18, 2024
  • Senior Vice President - Strategy & Business Development at Kartos Therapeutics, Inc.
    R. M.
    Senior Vice President - Strategy & Business Development
    Aug 28, 2026
  • Senior Vice President Clinical Development Operations at Kartos Therapeutics, Inc.
    J. M.
    Senior Vice President Clinical Development Operations
    Bay
    Sep 03, 2026
  • Vice President at Kartos Therapeutics, Inc.
    H. Q.
    Vice President
    Bay
    May 29, 2026
  • Director, Clinical Operations at Kartos Therapeutics, Inc.
    T. S.
    Director, Clinical Operations
    Bay
    May 26, 2026
  • Executive Director, Clinical Science at Kartos Therapeutics, Inc.
    E. P.
    Executive Director, Clinical Science
    Oct 22, 2024
  • Director, Finance at Kartos Therapeutics, Inc.
    T. B.
    Director, Finance
    Dec 21, 2023
  • Senior Clinical Trial Manager at Kartos Therapeutics, Inc.
    R. P.
    Senior Clinical Trial Manager
    United Kingdom, United Kingdom
    Sep 06, 2026
  • Senior Clinical Trial Manager at Kartos Therapeutics, Inc.
    A. K.
    Senior Clinical Trial Manager
    Bay
    Sep 12, 2026
  • Clinical Trial Manager at Kartos Therapeutics, Inc.
    M. S.
    Clinical Trial Manager
    Oct 17, 2024

Frequently Asked Questions

What is Kartos Therapeutics, Inc. known for?

Minus sign iconPlus sign icon
Kartos Therapeutics, Inc. was founded in 2018 and operates in the Biotechnology Research industry. You can contact Kartos Therapeutics, Inc.'s main corporate office by phone at . Explore Kartos Therapeutics, Inc.'s company overview page for more information.

What is Kartos Therapeutics, Inc.'s most common email format?

Minus sign iconPlus sign icon
Kartos Therapeutics, Inc. employees' email format typically follows the pattern of FLast@kartosthera.com. Trying to find reliable and up-to-date employee contact data? Find more Kartos Therapeutics, Inc. email formats with LeadIQ.

How many employees does Kartos Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
Kartos Therapeutics, Inc. has approximately 70 employees as of August 2026. These team members are located across 3 continents, including North America, Europe and Asia.

Who are Kartos Therapeutics, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Kartos Therapeutics, Inc.'s key employees include:

  • President: W. R.
  • Senior Vice President - Strategy & Business Development: R. M.
  • Senior Vice President Clinical Development Operations: J. M.
  • Vice President: H. Q.
  • Director, Clinical Operations: T. S.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.